Pregan ER 82.5 mg (Tablet (Extended Release))
Unit Price: ৳ 25.00 (2 x 10: ৳ 500.00)
Strip Price: ৳ 250.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Navana pharmaceuticals ltd |
| Also available as |
Title
- Pregan ER 82.5 mg XR Tablet
Categories
- Medicine
- Pharmaceuticals
- Healthcare
Description
- Anticonvulsant for neuropathic pain, shingles, seizures, and fibromyalgia
- Structural derivative of inhibitory neurotransmitter gamma-aminobutyric acid (GABA)
- Binds with high affinity to the alpha2-delta site in central nervous system tissues
- Operates anti-nociceptive and antiseizure effects
- Oral route of administration for regular tablets, taken with or without food
- Extended-release tablet administered after an evening meal, not to be split or crushed
- Adult dosage guidelines for different conditions and patient responses
- Pregnancy warning due to potential risk to fetus
- Contraindicated in patients with known hypersensitivity to Pregabalin or its components
- Common side effects include dizziness, somnolence, dry mouth, edema, blurred vision, weight gain, and altered thinking
- Caution for potential angioedema, hypersensitivity reactions, and increased risk of suicidal thoughts or behavior
- No established safety and effectiveness in pediatric patients
- Overdose effects including reduced consciousness, anxiety, restlessness, seizures, and heart block
- Storage in a cool, dry place below 30°C, protected from light and moisture
- Molecular Formula: C8H17NO2
Dimensions
- Tablet size: 82.5 mg XR
Color Options
- Not applicable
Functions
- Anti-nociceptive and antiseizure effects
Materials
- Pregabalin
Technical Specifications
- Maximum recommended dosages for different conditions and patient responses
- Drug interactions unlikely to cause significant pharmacokinetic effects
- No specific antidote in case of overdose
Design Elements
- Chemical structure: C8H17NO2
Usability Features
- Extended-release tablet for once-daily administration after an evening meal
Dosage
- Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN)
- Postherpetic neuralgia in adults (PHN)
- Management of fibromyalgia in adults
- Neuropathic pain associated with spinal cord injury in adults
- Conversion guidelines between regular and extended-release tablet dosages
Pregnancy & Lactation
- No well-controlled studies in pregnant women
- Potential risk to fetus
- Small amounts detected in lactating women's milk
- Breastfeeding not recommended during treatment
Precautions & Warnings
- Risk of angioedema, hypersensitivity reactions, and potential respiratory depression
- Increased risk of suicidal thoughts or behavior
- Caution for dizziness, somnolence, and impaired ability to operate machinery
- Peripheral edema and caution when coadministering with certain antidiabetic agents
Use in Special Populations
- No established safety and effectiveness in pediatric patients
- Not established for pediatric patients below the age of 1 month
Drug Classes
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Interaction
- Unlikely to cause significant pharmacokinetic drug interactions
- No significant drug interactions with food or others
Contraindications
- Known hypersensitivity to Pregabalin or its components
Side Effects
- Dizziness
- Somnolence
- Dry mouth
- Edema
- Blurred vision
- Weight gain
- Altered thinking
- Increased weight and appetite in pediatric patients
Overdose Effects
- Reduced consciousness
- Anxiety
- Restlessness
- Seizures
- Heart block
- No specific antidote
- General supportive care indicated
Commonly Asked Questions
- Duration of use until improvement is seen
- Frequency and timing of use
- Instructions for storage and disposal
- Disease-specific efficacy
- Necessity of continued use even if feeling fine
- Co-administration with other medications
- Potential for weight gain
Pregnancy Cat
- Not applicable
Administration
- Oral route of administration
- Extended-release tablet to be taken after an evening meal
- Tablets should not be split, crushed or chewed
- Guidelines for missed doses and gradual discontinuation
Storage Conditions
- Keep in a cool, dry place below 30°C
- Protected from light and moisture
- Keep out of reach of children
Compound Summary
- Chemical Structure: C8H17NO2
Interaction in Special Populations
- No specific information available
Additional Information
- Not applicable